ArticleJournal of medical virology2026
Prognostic Value of Admission Glucose and Extended Lipid Profile in Patients with Crimean-Congo Hemorrhagic Fever.
Article in Journal of medical virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Crimean-Congo hemorrhagic fever (CCHF) is a life-threatening viral hemorrhagic fever with a highly variable clinical course. While viral and inflammatory markers determining disease severity are well defined, the impact of the host's metabolic status on CCHF severity remains largely unexplored. The aim of this study is to investigate the relationship between metabolic syndrome components, lipid profile, and disease severity in patients with CCHF. This single-center, prospective, case-control study included 74 polymerase chain reaction (PCR)-confirmed CCHF patients and 31 healthy controls. Patients were stratified into mild and moderate-severe disease groups based on clinical findings and severity grading scores. Metabolic parameters, including body mass index (BMI), fasting blood glucose (FBG), and lipid profile, were compared between patient and control groups as well as according to disease severity. The patient and control groups were similar in terms of age, gender, BMI, and FBG levels. Low-density lipoprotein cholesterol (LDL-C), levels were significantly lower in CCHF patients compared to the control group (p = 0.042), while high-density lipoprotein cholesterol (HDL-C), levels were lower with borderline significance (p = 0.051). Patients in the moderate-severe disease group had significantly higher BMI (p = 0.010), FBG (p < 0.01), and triglyceride levels (p = 0.033) compared to those with mild disease. ROC analysis demonstrated that an FBG cut-off value of > 105 mg/dL had the highest discriminatory power in predicting severe disease (AUC: 0.761). In multivariate logistic regression analysis, FBG (OR: 1.026; 95% CI: 1.007-1.045; p = 0.007) was identified as independent factors associated with disease severity. Metabolic parameters, particularly FBG and triglyceride levels, are significantly associated with disease severity in CCHF. Evaluation of the metabolic status at admission may contribute to early risk stratification and the improvement of clinical management in CCHF patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.